Movement of apolipoprotein B into the lumen of microsomes from hepatocytes is disrupted in membranes enriched in phosphatidylmonomethylethanolamine

When monolayer cultures of rat hepatocytes are incubated with the ethanolamine/choline analogue, monomethylethanolamine, the secretion of apolipoproteins B100 and B48, as well as the lipid constituents, of very low density lipoprotein (VLDL) is inhibited by approximately 50% (Vance, J. E. (1991) J....

Full description

Saved in:
Bibliographic Details
Published in:The Journal of biological chemistry 1993-11, Vol.268 (33), p.25168-25175
Main Authors: Rusiñol, A E, Chan, E Y, Vance, J E
Format: Article
Language:English
Subjects:
Analytical, structural and metabolic biochemistry
Animals
Apolipoproteins B - biosynthesis
Apolipoproteins B - metabolism
Biological and medical sciences
Biological Transport - drug effects
cefalinas
Cell Membrane - drug effects
Cell Membrane - metabolism
cells
Cells, Cultured
cellule
celulas
cephaline
cephalins
cytoplasmic organelles
endoplasmic reticulum
foie
Fundamental and applied biological sciences. Psychology
higado
lipoproteinas
lipoproteine
lipoproteins
Lipoproteins, myelin
liver
Male
metabolisme des proteines
metabolismo proteico
Microsomes, Liver - drug effects
Microsomes, Liver - metabolism
organite cellulaire
organulos citoplasmicos
Phosphatidylethanolamines - pharmacology
protein metabolism
proteinas
proteine
Proteins
rat
rata
Rats
Rats, Sprague-Dawley
reticulo endoplasmatico
reticulum endoplasmique
secrecion
secretion
Trypsin - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:When monolayer cultures of rat hepatocytes are incubated with the ethanolamine/choline analogue, monomethylethanolamine, the secretion of apolipoproteins B100 and B48, as well as the lipid constituents, of very low density lipoprotein (VLDL) is inhibited by approximately 50% (Vance, J. E. (1991) J. Lipid Res. 32, 1971-1982). In the present study we have investigated the mechanism by which monomethylethanolamine disrupts VLDL secretion. Hepatocytes were treated with 400 microM monomethylethanolamine overnight, which resulted in an increase in the cellular content of the derived phospholipid, phosphatidylmonomethylethanolamine, from 0.32 +/- 0.15 to 2.92 +/- 0.74 nmol/mg of cell protein. The biosynthesis of apoproteins B100 and B48 was not impaired by treatment of cells with monomethylethanolamine. However, monomethylethanolamine decreased by approximately 50% the amount of apoproteins B, but not of the typical secretory protein, albumin, present in the luminal content subfraction of microsomes. The intracellular degradation of apoproteins B was also increased in phosphatidylmonomethylethanolamine-enriched, compared with control, cells. Moreover, the pool of apoprotein B present in intact microsomes from hepatocytes incubated with monomethylethanolamine was more accessible to exogenously added trypsin, presumably because a larger pool of the apoprotein B was exposed on the cytosolic surface of these microsomes. The data strongly suggest that an increase in the microsomal content of phosphatidylmonomethylethanolamine diminishes the ability of apoprotein B to translocate across the endoplasmic reticulum membrane into the luminal compartment. Consequently, the association of apoprotein B with lipids and/or the normal assembly of mature VLDL particles is impaired.
ISSN:0021-9258
1083-351X
DOI:10.1016/S0021-9258(19)74584-0